Agarose Bead Technologies will attend Europe’s largest cell and gene therapy conference and exhibition, the Advanced Therapies, which will take place in London (UK) from March 14-15.
The Advanced Therapies Congress, which takes place on March 14th and 15th in London, is set to feature an impressive line-up of speakers from across the entire value chain of cell and gene therapy development. The event will bring together forward-thinking pharma, biotech, and startup companies, researchers, clinicians, academics, HTAs, payers, and regulators to discuss the latest advancements in the field.
Agarose Bead Technologies (ABT) is excited to announce that Alvaro Silleras, Technical Sales Specialist, and Javier Peña, Sales and Marketing Specialist, will be attending the event. They will be representing the company and sharing their latest innovations and expertise with attendees from around the world.
With eight tracks of content, the agenda promises to cover everything from manufacturing, supply chain & logistics, pricing & market access, to developments in key therapeutic areas such as cell therapy, gene therapy, gene-modified cell therapy, gene editing, stem cells, and regenerative medicine.
In a time of great uncertainty for the biotech industry, the Advanced Therapies Congress provides an important platform for the leaders of biotech, pharma, fast-growing industry start-ups, and established solution providers to share their insights and to forecast where cell and gene therapy is heading next.